Idiopathic Pulmonary Fibrosis: all 565 studies
Page 1 of 6. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Doses of Inhaled CHF10073 in Participants With Idiopathic Pulmonary FibrosisNot yet recruitingNCT07876284Phase 1
- Study of ORJ-001 for the Treatment of IPFRecruitingNCT07869147Phase 2
- Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) TabletsRecruitingNCT07868419Phase 3
- A Trial of AGMB-447 in Participants With Idiopathic Pulmonary FibrosisNot yet recruitingNCT07862634Phase 2
- Inspiratory Flow Rate Capability in Pulmonary Fibrosis PatientsRecruitingNCT07820254
- Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary FibrosisRecruitingNCT07790614
- Blood Cell Count Derived Inflammatory Indexes in Acute Exacerbation of Idiopathic Pulmonary FibrosisNot yet recruitingNCT07783230
- Evaluating the Efficacy and Safety of of HSK50042 in People With Idiopathic Pulmonary FibrosisNot yet recruitingNCT07728721Phase 2
- Predictors of Pulmonary Embolism in Interstitial Lung Disease With Worsening SymptomsNot yet recruitingNCT07728448
- Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung DiseaseRecruitingNCT07723872
- New Diagnostic Approaches in the Management of Inflammatory Lung DiseasesNot yet recruitingNCT07723638Not applicable
- Antifibrotic Therapy Decision-Making in Pulmonary FibrosisNot yet recruitingNCT07722507
- A Phase 3 Study of Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary FibrosisNot yet recruitingNCT07719023Phase 3
- Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary NeoplasiaRecruitingNCT07707245Not applicable
- Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT07687459Phase 3
- Study of Single and Multiple Oral Doses of SCB0020160 in Healthy Adult Male SubjectsNot yet recruitingNCT07682337Phase 1
- Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary FibrosisRecruitingNCT07679893Phase 2
- Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary FibrosisNot yet recruitingNCT07674745Phase 2
- Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote MonitoringRecruitingNCT07673237Not applicable
- Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) TabletsRecruitingNCT07671911Phase 3
- A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.RecruitingNCT07652658Phase 2
- A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary HypertensionNot yet recruitingNCT07613216
- A Phase II Study to Evaluate the Efficacy and Safety of SYH2059 Tablets in Adult Patients With Idiopathic Pulmonary FibrosisNot yet recruitingNCT07600021Phase 2
- A Phase I Study of HW241045 in Healthy SubjectsNot yet recruitingNCT07593690Phase 1
- Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis (IPF)Not yet recruitingNCT07583589Phase 2
- Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary FibrosisNot yet recruitingNCT07520110Phase 3
- A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary FibrosisRecruitingNCT07516951Phase 2
- Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for Idiopathic Pulmonary FibrosisNot yet recruitingNCT07515066Phase 1
- Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 TrialRecruitingNCT07482917Not applicable
- Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.RecruitingNCT07466420Not applicable
- A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT07464912Phase 3
- A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy ParticipantsRecruitingNCT07454291Phase 1
- Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary FibrosisRecruitingNCT07447102Phase 2
- Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary FibrosisNot yet recruitingNCT07441408Phase 3
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult MalesRecruitingNCT07407543Phase 1
- OPEN-IPF: Observational Prediction modEl for cliNical Outcomes in Idiopathic Pulmonary FibrosisNot yet recruitingNCT07404423
- Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell TherapyNot yet recruitingNCT07359963Early Phase 1
- A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic MedicationsRecruitingNCT07332117
- CAR-DC for End-Stage IPFNot yet recruitingNCT07329959Phase 1
- Small Airways Disease Functional Assessment in Idiopathic Pulmonary Fibrosis (SWIFT-IPF)RecruitingNCT07312305
- Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary FibrosisRecruitingNCT07299695Phase 3
- Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT07284602Phase 3
- Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary FibrosisRecruitingNCT07284459Phase 2
- Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary FibrosisRecruitingNCT07230288Phase 2
- AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPFRecruitingNCT07194382Phase 2
- Motivational Interviewing Program on the Self-Care in Idiopathic Pulmonary FibrosisNot yet recruitingNCT07179562Not applicable
- Disease-syndrome Characteristics of IPFNot yet recruitingNCT07178392
- Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed TomographyRecruitingNCT07174102
- Idiopathic Pulmonary Fibrosis Cohort of TCMNot yet recruitingNCT07162870
- Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary FibrosisNot yet recruitingNCT07131150Phase 2
- A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary FibrosisRecruitingNCT07121413Phase 2
- Confirmatory Clinical Study of HEC585 Tablets in Patients With IPFRecruitingNCT07082842Phase 3
- Daoyin Technique for Improving Exercise Endurance in IPFRecruitingNCT07019714Not applicable
- Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)Not yet recruitingNCT07019090Phase 2
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesRecruitingNCT07002034Phase 2
- A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary FibrosisRecruitingNCT06968845Phase 2
- An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)RecruitingNCT06951217Phase 2
- Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective StudyNot yet recruitingNCT06922916
- Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPFRecruitingNCT06914713Not applicable
- D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal FibrosisRecruitingNCT06909409
- Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary FibrosisRecruitingNCT06853145Early Phase 1
- Downhill Walking in IPFRecruitingNCT06756230Not applicable
- SB17170 Phase 2 Trial in IPF PatientsRecruitingNCT06747923Phase 2
- Senicapoc in Patients With Worsening Fibrotic Interstitial Lung DiseaseRecruitingNCT06714123Phase 2
- Precision Diagnosis and Care for Families With Pulmonary Fibrosis in IrelandRecruitingNCT06702228
- Determination of Functional Exercise Capacity, Respiratory Muscle Endurance in Idiopathic Pulmonary FibrosisNot yet recruitingNCT06668051
- P4O2 ILD ExtensionRecruitingNCT06644144
- Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary FibrosisEnrolling by invitationNCT06629623
- Zinc and Nicotinamide Riboside for Idiopathic Pulmonary FibrosisRecruitingNCT06567717Phase 2
- Clinical Genetics and Screening for Idiopathic Pulmonary FibrosisNot yet recruitingNCT06521125
- Pilot Study of Nitrate-rich Beetroot Juice Supplementation in Patients With Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT06488638Not applicable
- A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy VolunteersRecruitingNCT06482190Phase 1
- Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation.RecruitingNCT06445686
- H01 in Adults With Interstitial Lung Disease (The SOLIS Study)RecruitingNCT06325696Phase 2
- The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary FibrosisRecruitingNCT06323876
- A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.RecruitingNCT06267183Early Phase 1
- Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung DiseasesRecruitingNCT06189820Phase 2
- SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT06125327Phase 2/3
- A Clinical Trial on the Treatment of Idiopathic Pulmonary FibrosisNot yet recruitingNCT06102083Phase 2
- Interstitial Lung Disease: A Study From Infancy to Elderly Including RelativesRecruitingNCT06036719
- Heart Rate Variability and Nocturnal Blood Oxygen Saturation in Patients With Idiopathic Pulmonary FibrosisRecruitingNCT06027372
- Validation of the C-mo System - Cough MonitoringRecruitingNCT05989698Not applicable
- Dose-Escalation Study of Artesunate Patients With IPFRecruitingNCT05988463Phase 1
- Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary FibrosisRecruitingNCT05975983Phase 2
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Immunogenicity of 9MW3811 in Healthy SubjectsRecruitingNCT05912049Phase 1
- Respiratory Rate Validation Study - HiCardi+ Wearable Patch Device, Mezoo Co., Ltd.RecruitingNCT05863091Not applicable
- Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary FibrosisRecruitingNCT05842681Not applicable
- Faecal Microbiota Transplantation to Ameliorate Nintedanib-induced Diarrhea in Patients With Idiopathic Pulmonary FibrosisNot yet recruitingNCT05755308Not applicable
- Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT05571059Phase 2
- Interstitial Lung Disease Research Unit BiobankRecruitingNCT05392881
- Pulmonary Fibrosis Foundation Community RegistryRecruitingNCT05382572
- Optimising Screening for Early Disease Detection in Familial Pulmonary FibrosisRecruitingNCT05367349
- Deep Learning Diagnostic and Risk-stratification for IPF and COPDRecruitingNCT05318599
- End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical VentilationRecruitingNCT05098717
- Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF).RecruitingNCT05052229Early Phase 1
- Effects of Pulmonary Diseases and Their Treatment on Cardiac FunctionRecruitingNCT05042219
- ILD-SARDs Registry and BiorepositoryRecruitingNCT05007340
- Treating People With Idiopathic Pulmonary Fibrosis With the Addition of LansoprazoleRecruitingNCT04965298Phase 3
- Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung DiseaseEnrolling by invitationNCT04905693Phase 3
- University of Virginia Natural History StudyEnrolling by invitationNCT04896138